NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

During the first quarter, the Harbor Long Term Growers ETF returned -10.09% (at NAV), underperforming the benchmark, the Russell 1000® Growth Index, which returned -9.97%. We initiated a position in Nike, one of the world's premier brands with an unparalleled roster of global athletes. During the quarter, we reduced our allocation to Information Technology and increased it to Health Care, as well as Financials.

ETFs like VGK, EZU and FEZ are set to rally as the ECB's latest rate cut and dovish tone bolster the outlook for European equities.

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wabash National Corporation (“Wabash” or the “Company”) (NYSE: WNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=152000&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd. ("Biohaven Ltd.

NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cable One, Inc. ("Cable One, Inc.") (NYSE:CABO) concerning possible violations of federal securities laws. On May 2, 2025, Cable One missed earnings expectations by nearly $8 and suspended its dividend.

NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Photronics, Inc. ("Photronics, Inc.") (NASDAQ:PLAB) concerning possible violations of federal securities laws. Photronics issued a press release on May 28, 2025, reporting its financial results for the second quarter of 2025.

NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=152002&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151998&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=151999&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Explore Baker Hughes Co's innovative energy solutions and digital transformation strategies with insights into their technology initiatives, partnerships, product launches, and more. Discover their focus on innovation across the Americas, Europe, Middle East, Africa, and Asia. Unlock key tech insights now! Explore Baker Hughes Co's innovative energy solutions and digital transformation strategies with insights into their technology initiatives, partnerships, product launches, and more. Discover their focus on innovation across the Americas, Europe, Middle East, Africa, and Asia. Unlock key tech insights now!

FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has approved Phathom's Citizen Petition filed on December 11, 2024 and communicated the Agency's intention to correct the Orange Book to recognize the proper 10 years of New Chemical Entity exclusivity for VOQUEZNA® (vonoprazan) tablets, extending through May 3, 2032.

Medicus Pharma (NASDAQ:MDCX) said it has appointed KPMG as its independent registered public accounting firm for the 2025 fiscal year, replacing EisnerAmper following a review process led by the company's audit committee and approved by its board. The transition, announced on June 4, comes as the clinical-stage biotech company ramps up its global operations and research programs.

Brinker International, Inc. EAT stock has risen 21.9% in the past month, outpacing the industry and the S&P 500's growth of 2.1% and 6.2%, respectively. The ongoing increase in traffic continues to drive the company's performance.

Amazon.com Inc (NASDAQ:AMZN)'s growing investment in robotics represents a significant long-term cost-saving and margin-enhancing opportunity, analysts at Bank of America believe. The analysts have a ‘Buy' rating on Amazon and a $248 price target, implying upside from Friday's share price of about $212.

As Apple heads into its annual developers conference this coming week, it is facing a slew of problems that has led to a stock price slide of 20% this year thus far, the worst performance since at least 2010.